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Abstract
Obesity develops due to energy (food) intake exceeding energy expenditure. Nutrients that reduce the positive 
energy balance are thus being considered as therapies to combat obesity. Here, we review the literature related to 
the physiological, cellular and endocrine effects of intake of whey proteins, namely α-lactalbumin, β-lactoglobulin, 
glycomacropeptide and lactoferrin. Moreover, we discuss how dietary composition and obesity may influence whey 
protein effects on the above parameters. Evidence suggests that intake of whey proteins causes a decrease in energy 
intake, increase in energy expenditure, influence insulin sensitivity and glucose homeostasis and alter lipid metabolism 
in the adipose, liver and muscle. These physiological changes are accompanied by alterations in the plasma levels of 
energy balance related hormones (cholecystokinin, ghrelin, insulin and glucagon-like peptide-1) and the expression of 
catabolic and anabolic genes in the above tissue in the direction to cause a negative energy balance.
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Introduction
Obesity is a major health problem in the world because it increases 
the risk of development of several clinical conditions including 
cardiovascular disease, stroke, hypertension and type 2 diabetes [1]. 
The weight gain occurs due to storage of energy consumed in excess 
of daily requirement, as triacylglycerol (TAG) in the adipose tissue. 
The resulting increase in the mass of the adipose tissue causes the 
gain of weight, and it may even lead to the development of obesity [2]. 
The prevalence of obesity and associated co-morbidities has reached 
epidemic proportions globally. Hence, it is no surprise that there is a 
growing interest to identify therapies in particular those involving 
nutrients that could reduce weight gain and thus the development of 
obesity. 
Whey is the milk serum that remains after precipitation of 
casein during cheese production, and it contains proteins, vitamins, 
minerals and trace amounts of fat. Whey associated proteins include 
α-lactalbumin, β-lactoglobulin, glycomacropeptide and lactoferrin 
[3]. There is accumulating evidence suggesting that whey protein 
intake influences the balance between energy (food) intake and energy 
expenditure, insulin sensitivity and glucose homeostasis as well as lipid 
metabolism in tissues in particular in the adipose tissue. Here, we review 
data from in vivo (human and rodent) and in vitro studies related to the 
above effects of α-lactalbumin, β-lactoglobulin, glycomacropeptide and 
lactoferrin and briefly discuss in the last section the actions of recently 
identified minor whey proteins. Furthermore, we discuss how dietary 
composition and obesity could influence the actions of these dietary 
proteins. Because authors of some of the studies mentioned below have 
not stated whether the whey proteins were provided as a concentrate or 
isolate, we have used the term “whey proteins” where this classification 
has not been specified.
Food (Energy) Intake
Studies conducted in humans have shown that intake of 20 to 50 g 
of whey proteins reduces short term ad libitum food intake. Akhavan 
et al. showed that whey protein concentrate (20-40 g) dose dependently 
reduces subsequent (30 min) ad libitum pizza meal energy intake in 
lean subjects, with 40g having the greatest impact compared to the 
water control [4]. This effect extends up to 2 h in lean subjects [5]. In 
comparison to casein, whey proteins (48 g) delay the desire to eat a 
subsequent meal by up to 180 mins in lean subjects [6], suggesting that 
the whey proteins induce satiety in comparison to casein intake. The 
results of rodent studies with regard to the effects of whey proteins 
on food (energy) intake are largely in agreement with that observed 
in humans. The suggestion that whey proteins induce satiety has 
been further confirmed in mice by showing that whey protein isolate 
providing 30% energy increased intermeal interval (satiety) compared 
to soy protein during the 7 day period of the study [7]. Similar findings 
have been reported from a long term study lasting 10 weeks [8]. 
These data are consistent with the findings from human studies that 
whey proteins reduce food intake by inducing satiety in the lean state. 
However, a functional relationship between whey proteins and food 
intake has not been consistently reported. For instance, although Hall 
et al. showed that whey proteins reduce food intake compared to casein 
in humans [6], this response was not observed in rats given a whey 
protein isolate in comparison to casein diet (300 g/kg diet) for 7 weeks, 
despite the fact that the rats on the whey protein isolate diet showed a 
significantly reduced weight gain compared to the rats on the casein 
diet [9]. It is possible that physiological and neuroendocrine differences 
that exist between the species (humans vs. rats) may have given rise 
to the inconsistent effects of whey protein and casein on food intake. 
There is evidence that macronutrient composition in the diet could also 
impact upon the effect of whey proteins on food intake. Veldhorst et al. 
showed that a diet containing proteins, carbohydrates and fat providing 
10, 55 and 35% energy, respectively, reduces hunger in humans if whey 
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proteins were included in comparison to either soy and casein [10]. 
Similar results have been obtained from a study conducted in rats, 
which showed that whey protein concentrate with energy content of 
55% reduced cumulative energy intake compared to whole milk protein 
if the former protein had been supplied in a diet with either 35% and 
10% energy from carbohydrates and lipids, respectively, or in a diet 
with 45% energy solely from lipids [11]. No differences in cumulative 
energy intake were observed if the proteins were provided in diets with 
15% and 30% energy from carbohydrates and fats, respectively. These 
data highlights the importance of the carbohydrate composition in 
the diet on whey protein effects on food intake. In addition to dietary 
composition, weight gain also seems to influence the effect of whey 
proteins on short term food intake. This is revealed by the finding 
that intake of whey protein isolate (50 g) reduced subsequent pizza 
intake in normal weight but not in obese subjects [12]. Similar findings 
have been reported by another human study [13] and in high fat diet 
induced obese mice [14]. In the latter case, diet induced obese mice that 
drank water supplemented with whey protein isolate at 100 g/L for 11 
weeks show similar energy intake to obese mice on un-supplemented 
water, despite the former group showing a significant decrease in body 
weight [14]. Thus, in addition to protein source, quality and time of 
consumption mentioned by Anderson et al. [5], both macronutrient 
composition in the diet and state of energy balance (lean vs. obese), 
should be considered as important factors influencing the whey protein 
effects on food intake.
A number of studies have attempted to identify the individual 
whey proteins present in the concentrate or isolate that might be 
causing the reduction in food intake in humans and rodents. Because 
glycomacropeptide has been shown to stimulate the production of 
the satiety hormone cholecystokinin (CCK) [15], a role for this whey 
protein in the regulation of food intake has been suggested. The findings 
of Veldhorst et al. support the latter suggestion, since it was shown that 
ingestion of a breakfast diet with whey protein providing 10% energy 
reduced lunchtime energy intake in lean subjects more than intake of 
a whey protein associated breakfast diet without glycomacropeptide 
[16]. This suggests that glycomacropeptide may reduce energy intake 
possibly by inducing satiety, as previously reported. This finding is not 
in agreement with data from several other studies performed on lean 
subjects with diets containing whey protein without glycomacropeptide 
(providing 44% energy) [17] and whey protein diets with added 
glycomacropeptide (21% w/w) [18]. To explore the possibility that 
the discrepancies in the data on the effects of glycomacropeptide on 
food intake might be due to the variations in the degree of protein 
glycosylation, Keogh et al. provided 50 g of minimal glycosylated or 
glycosylated glycomacropeptide as well glycomacropeptide depleted 
whey protein concentrate to obese and overweight subjects and found 
that their subsequent lunch time meal intake was not affected by the 
dietary challenges [19]. The data suggest that the degree of glycosylation 
studied in the glycomacropeptide is not critical for the actions of this 
whey protein on food intake. As the above study was performed on 
obese or over-weight individuals that as described above appear to 
be less sensitive to whey protein effects on food intake, it would be 
interesting to find out whether the outcome on food intake would be 
different with lean individuals. However, taking in to account the data 
from human studies described above, and data from a rat study which 
revealed that glycomacropeptide does not impact on food intake [9], 
it could be argued that this whey protein does not have a significant 
effect on this physiological process. Utilising a similar approach as in 
their previous studies, Veldhorst et al. showed that breakfast diets with 
α-lactalbumin providing 10% or 25% energy reduces lunch time energy 
intake in lean subjects compared to a breakfast diet with casein, soy or 
whey without glycomacropeptide [20]. This data is in agreement with 
the results of another study [21], which together suggest an important 
role for α-lactalbumin in suppression of food intake in lean humans. 
In addition to this whey protein, β-lactoglobulin has also been shown 
to influence energy intake. The study by Pichon et al. that showed data 
highlighting the importance of dietary composition on whey protein 
effects on energy intake, also tested the effects of β-lactoglobulin 
on energy intake in rats and found that β-lactoglobulin reduced 
energy intake compared to whole milk proteins [11]. In summary, 
consumption of whey proteins as an isolate or concentrate appears to 
reduce food (energy) intake in humans and rodents by inducing satiety 
compared to casein, soy or carbohydrates. This effect is influenced by 
the macronutrients in the whey protein diet and by development of 
obesity. In the former case, a high carbohydrate composition appears 
to favour the actions of whey proteins. Of the whey proteins that have 
been studied, data suggests an important role(s) for α-lactalbumin 
and β-lactoglobulin in the regulation of food (energy) intake, with no 
significant regulatory role for glycomacropeptide in this physiological 
process.
Lipid Metabolism
In over-weight or obese humans and rodents, whey proteins have 
been shown to improve lipid metabolism, particularly elevated plasma, 
adipose and hepatic TAG levels. Recently Pal et al. demonstrated that 
intake of whey protein isolate (27 g) twice daily for 12 weeks causes 
a reduction in fasting TAG levels in over-weight and obese subjects 
compared to casein intake [22]. A similar effect has also been observed 
in obese rats with intake of whey protein concentrate at 32% (wt/wt) 
compared to 8% (wt/wt) [23]. Even at a reduced whey protein isolate 
content (24% wt/wt providing 18% energy), these dietary proteins 
reduce high fat (providing 60% energy) diet induced weight gain and 
body fat in mice compared to casein intake [24]. The reduction in body 
weight and fat content observed by the latter study was not due to a 
difference in the intestinal fat absorption in the two groups. The authors 
thus investigated whether whey protein isolate may affect adipocyte 
lipid metabolism [25]. By providing the same high fat diets containing 
either whey protein isolate or casein for 21 weeks, it was shown that 
the adipocyte cross sectional area was reduced in mice fed with whey 
proteins compared to casein. This suggests that whey proteins influence 
lipid metabolism in adipocytes much more than casein, although the 
extent of the reduction in adipocyte size may have been influenced by 
the fact the diets contain calcium, which is known to influence lipid 
metabolism in this tissue [26]. Given that the liver is also important for 
regulation of lipid metabolism, the same authors assessed in a separate 
study how the same dietary challenge may impact upon the lipid 
metabolism in the liver of high fat diet-induced obese mice subjected 
to a 7 week calorie restriction [27]. Compared to calorie restricted 
obese mice on the casein diet, calorie restricted obese mice on the whey 
protein isolate diet had reduced TAG levels in the liver. The specificity 
with which whey protein isolate influences hepatic lipid content has 
been further demonstrated (in the absence of calorie restriction) by the 
study by Shertzer et al. [14]. In the studies mentioned above, except 
for the latter, the observed effects of whey protein on lipid metabolism 
were shown relative to casein. Interestingly, in contrast, soy proteins 
at 24% (wt/wt) in the diet of rats had a similar effect on body weight 
and abdominal fat as whey proteins [8]. This data could be interpreted 
to suggest that whey protein effects on lipid metabolism are detectable 
only when casein is used as the control protein, or that the lack of an 
effect on lipid metabolism in comparison to soy might be due to the 
fact that the above study assessed dietary protein effects on lean rats 
as oppose to obese rodents, which are known to have a higher body 
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weight and body fat content and thus, are likely to be more susceptible 
to whey protein effects on lipid metabolism. A number of studies have 
attempted to determine how each individual whey protein affects lipid 
metabolism. Two human studies show date related to the actions of 
lactoferrin and glycomacropeptide. By providing overweight human 
subjects with enteric coated lactoferrin (100 mg/d) or placebo tablets 
for a period of 8 weeks, it has been found that lactoferrin reduces body 
weight, visceral fat mass as well as hip circumference [28]. In contrast, 
ingestion of glycomacropeptide-enriched whey protein diet (with 15 g 
of proteins) twice daily replacing two daily meals for 6 months or once 
daily for further 6 months, had no significant effect on body weight 
or plasma TAG concentrations compared to skim milk powder diet 
[29]. It would be interesting to further define whether the outcome 
would have been different if a higher glycomacropeptide content 
was used, given also that data from a rodent study described below 
suggests an important role for this whey protein in the regulation of 
lipid metabolism. It has been shown that rats ingesting whey protein 
isolate diet supplemented with glycomacropeptide at 100 and 200 g/
kg reduces carcass fat compared to in rats on a whey protein isolate 
diet or casein diet [9]. Because there were no differences in food intake 
between the groups, the data suggests a food intake-independent 
effect of glycomacropeptide on lipid metabolism (fat content) in these 
animals. With the view to assessing how other whey proteins, namely 
α-lactalbumin, β-lactoglobulin and lactoferrin may influence body 
weight and body fat content in rodents, Pilvi et al. subjected high fat 
diet induced obese mice to a 70% energy restricted diet containing 
whey protein isolate or each of the whey proteins mentioned above 
(18% energy) for a period of 7 weeks to induce weight loss [30], and 
subsequently allowed ad libitum access to the diets for further 7 weeks 
to allow weight gain. Results suggest that α- lactalbumin is the most 
beneficial whey protein in terms of causing fat loss when provided as 
part of an energy restricted diet or fed ad libitum. Although lactoferrin 
caused the most weight loss and had a similar effect on percentage fat 
content to α-lactalbumin in the initial 7 weeks, during the ad libitum 
feeding period however, lactoferrin caused the most gain in total fat 
content. In contrast, the human study mentioned above found that 
lactoferrin reduces body weight and fat content [28]. In further support 
for a role for lactoferrin in reducing adiposity, it has been shown in 
vitro that this whey protein specifically inhibits adipogenesis and 
lipid accumulation in adipocytes [31,32]. Although Pilvi et al. study 
showed that β-lactoglobulin was the least effective whey protein for 
inducing weight loss and for preventing weight gain [30], Pichon et al. 
found that β-lactoglobulin (55% energy) causes the least weight gain 
when supplemented in a diet containing only fat providing 45% of 
energy in comparison to a diet containing 35% and 10% energy from 
carbohydrates and fat or in a diet with 15% and 30% energy from the 
same macronutrients, respectively [11]. The data again highlights the 
importance of macronutrient composition on whey proteins effects 
on energy balance. Note here that the macronutrient composition 
providing the maximum whey protein effects on body weight and 
body fat content appear to differ from the composition that seemed 
to provide a greater reduction in food intake mentioned previously; in 
both cases however, a diet with carbohydrate and fat providing 35% 
and 10% energy respectively appear to be effective to bring about 
both changes in food intake and body weight/lipid metabolism. In 
summary, whey protein isolate appears to reduce body weight and lipid 
metabolism both in obese humans and in rodents in comparison to 
casein intake, with specific effects observed in the adipocytes and in the 
liver, although these effects appear to be influenced by macronutrient 
composition in the diet. Available data suggest an important role(s) for 
α-lactalbumin, β-lactoglobulin, lactoferrin and glycomacropeptide in 
the regulation of lipid metabolism in humans and/or in rodents.
Insulin Sensitivity and Glucose Homeostasis
In healthy and overweight humans and rodents whey protein intake 
has been shown to cause an acute insulinotropic response. This has 
been shown by supplementation of whey proteins into glucose drinks 
or test meals, which augments postprandial insulin release, resulting in 
an enhancement of glucose disposal in both healthy [33,34] and type-
2 diabetic [35] subjects. Similar effects have been seen in anesthetised 
mice, where gastic gavage of whey protein (75 mg) and glucose (75 mg) 
together augmented the insulin response 3-fold and increased glucose 
disposal by 31% in comparison to glucose alone [36]. In addition 
to acute responses, prolonged whey protein intake also improves 
insulin sensitivity in the obese state in both rodents [14,23,27,37,38] 
and humans [22]. Of the whey proteins that have been tested, both 
α-lactalbumin and glycomacropeptide have been found to increase the 
postprandial insulin release (in comparison to casein protein intake) 
with glycomacropeptide having a greater effect than whey protein 
isolate or α-lactalbumin [16]. Long-term glycomacropeptide intake 
has also been shown to improve fasting blood insulin levels in both 
humans [29] and rats [9]. Similarly a high protein diet (55% kcal) with 
β-lactoglobulin as it source of protein was shown by Pichon et al. [11] 
to reduce insulin resistance and improve fasting blood insulin levels 
in rats to a greater extent than that of comparable high whey protein 
concentrate diet. The actions of α-lactalbumin and β-lactoglobulin on 
insulin sensitivity and glucose homeostasis may be due to the bioactive 
peptides in the proteins, since several dipeptides from α-lactalbumin 
and β-lactoglobulin have been found to increase glucose uptake in 
L6 myotubes and isolated skeletal muscles in vitro [39]. A role for 
lactoferrin in the regulation of glucose homeostasis has also been 
suggested based on the findings that circulating levels of lactoferrin 
correlate negatively with hyperglycemia and positively with insulin 
sensitivity [40], and that intake of a lactoferrin rich whey protein 
isolate supplemented high fat diet improves glucose tolerance in mice 
in comparison to high fat diet containing casein [38]. In summary, 
whey protein intake appears to stimulate insulin release and could 
improve glucose tolerance and insulin sensitivity long term, even when 
accompanied by high fat feeding. The available data also suggest that 
this effect may be a common feature of α-lactalbumin, β-lactoglobulin, 
lactoferrin and glycomacropeptide, with the latter being more potent 
than α-lactalbumin.
Energy Expenditure
Whey protein (18 g) intake prior to a bout of heavy resistance 
training increases post-training resting energy expenditure in humans 
compared to carbohydrate intake [41]. Interestingly, this effect 
diminishes if the whey protein meal was ingested after the resistance 
exercise, even if the protein content in the diet was at 30 g [42]. The 
data suggest that the timing of the dietary challenge is crucial for 
detecting whey protein induced changes in resting energy expenditure. 
Intake of whey proteins also appears to increase thermogenesis, 
possibly because of its higher thermic effect compared to soy or 
casein [33]. This may possibly be due to the whey protein induced 
increased protein metabolism in tissues [43]. To our knowledge, of 
the whey proteins associated with regulation of energy balance, only 
α-lactalbumin has been shown to influence energy expenditure. 
The study by Hursel et al. which reported an effect of α-lactalbumin 
(41% energy from the protein) ingestion on lunchtime meal intake in 
the healthy humans, also found that this whey protein significantly 
increases diet-induced thermogenesis compared to intake of whole 
milk protein rich diet [21]. Whether α-lactalbumin, or any other whey 
protein, could influence energy expenditure in obese humans remains 
to be determined, although data from a rodent study clearly suggests 
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such an effect; it has been shown that diet-induced obese mice drinking 
water supplemented with whey proteins (100 g/L) have increased O2 
consumption compared to obese mice drinking unsupplemented water 
[14]. In summary, compared to carbohydrates, soy and casein, intake of 
whey proteins appears to increase energy expenditure in lean and obese 
states by influencing thermogenesis and resting energy expenditure. In 
the latter case, the timing of the dietary challenge might be important, 
in particular when associated with exercise, for obtaining an effective 
change in this parameter linked to energy expenditure. It is tempting to 
suggest that the effect of whey proteins on energy expenditure might be 
due to the actions of α-lactalbumin present in the whey protein isolate 
or concentrate, however, this may be premature given that there are 
no data showing whether other whey proteins could influence energy 
expenditure to the same extent.
Cellular Activity and Endocrine System
It is well established that the hormones CCK, ghrelin, insulin and 
glucagon-like peptide-1 (GLP-1) play important roles in energy balance 
regulation by inhibiting (CCK, insulin and GLP-1) and stimulating 
(ghrelin) food (energy) intake and/or by inducing a catabolic (GLP-
1) and anabolic (ghrelin and insulin) responses on lipid metabolism 
in tissues [44,45]. Given the effects of whey proteins on food intake 
and body weight, it is no surprise that whey proteins modulate these 
hormones. A study by Bowen et al. showed that whey protein induced 
decrease in energy intake in humans, is accompanied by an increased 
plasma level of CCK and GLP-1 and reduces levels of ghrelin [46]. 
These changes were noted as early as 15 mins and continued up to 
180 mins after the dietary challenge, suggesting potential acute and 
chronic effects of whey proteins on hormonal levels. In the case of 
insulin, whey proteins appear to acutely increase hormone levels, but 
over a time, there is a notable decline. Similar effects on hormone levels 
have been observed in studies conducted with only lean [6] and obese 
subjects [13], suggesting that whey proteins modulate hormone levels 
independent of weight gain and that the changes are consistent with an 
attempt to increase catabolism. Similar data have been obtained from 
rodent studies. Zhou et al. showed that the reduction in food intake 
in lean rats on a diet supplemented with 24% (wt/wt) whey protein 
concentrate, is accompanied by an increased GLP-1 level in the plasma 
[8]. Given that both α-lactalbumin and β-lactoglobulin have been 
shown to influence food (energy) intake, it would be interesting to find 
out whether these proteins are responsible for the observed changes in 
hormone levels detected in human and rodent studies.
An advantage of conducting rodent studies in comparison to 
human studies is that in the former case, it is possible to dissect and 
analyse tissues of interest to identify specific changes in expression of 
energy balance related genes. To our knowledge, such investigations 
have not been conducted to assess the impact of whey proteins on gene 
expression in centres of the brain important for regulation of energy 
balance. In contrast, there is data to suggest that whey proteins influence 
gene expression related to lipid metabolism in the adipocytes and in 
the liver cells. The study by Pilvi et al. mentioned above performed 
a detailed microarray analysis of gene expression in the (reduced) 
adipocytes of obese mice that had ingested whey proteins [25]. This 
analysis revealed an increased expression of several genes involved in 
insulin signalling pathway in the whey protein group compared to the 
control casein group. The microarray data also revealed an increased 
expression of genes for leptin and β3-adrenergic receptor. Since the 
mass of the adipose tissue and leptin gene expression has previously 
been shown to be closely linked [47], the significance of the increased 
expression of leptin gene in adipocytes with reduced cross sectional 
area remains to be determined. In contrast, a potential functional 
relationship could exist between the reduction in the adipose tissue and 
increased β3-adrenergic receptor expression, given that the receptor 
activation is known to increase hormone sensitive lipase-mediated 
hydrolysis of fat, increase fat oxidation and induce uncoupling protein-
mediated thermogenesis [48,49], all of which are likely to reduce mass of 
the adipose tissue. This also indicates a potential mechanism by which 
whey proteins could reduce adiposity. With regard to the rat liver, whey 
proteins have been found to reduce activity of several lipogenic enzymes 
including fatty acid synthase (FAS) compared to casein intake [50]. In 
contrast, in the muscle, FAS expression and activity was increased in 
response to whey protein challenge [50], possibly to reduce hepatic 
production of lipids and to promote synthesis of lipids in the muscle so 
that these could be oxidised in the mitochondria in the muscle cells to 
generate energy in the form of adenosine 5’ triphosphate. With regard 
to the above mentioned changes in the cellular activity observed in the 
adipose, muscle and liver, it is important to further define how they 
arise by investigating the impact of the whey proteins implicated in 
lipid metabolism, namely α-lactalbumin, β-lactoglobulin, lactoferrin 
and glycomacropeptide. In summary, in comparison to casein and 
carbohydrates (glucose and fructose), whey proteins appear to drive 
endocrine and cellular changes consistent with a catabolic effect. This 
is achieved by up-regulation of the production of catabolic hormones 
(CCK, GLP-1 and insulin), by reduction in the production of anabolic 
hormone ghrelin and by modulation of the expression or activity of 
lipogenic, lipolytic and fat oxidation related genes in the liver, adipose 
and in the muscle. The decrease in insulin levels observed over time 
with whey protein intake might be a mechanism to reduce anabolic 
effects of this hormone on adipocytes [45].
Minor Whey Proteins
In addition to the above mentioned whey proteins, many other 
lower-abundance proteins have been found within the whey fraction. 
Due to recent advances in milk proteomics [51,52], this list of minor 
whey proteins is increasing. In fact, a recent proteomic investigation of 
the whey fraction has found 293 unique gene products, 176 of which were 
newly identified in whey [52]. Although the potential energy balance 
related roles of these minor whey proteins have yet to be investigated, 
it is interesting that some of these proteins such as lipoprotein lipase, 
perilipin-2 and fatty acid binding proteins 3 and 5, have defined roles 
in lipid metabolism and storage. Recently, a study assessed the impact 
of a novel whey protein isolate rich in lactoperoxidase on high fat diet 
induced obesity [38] and found that this diet dose-dependently reduced 
bodyweight, fat mass gain, hepatic lipid accumulation and improved 
glucose tolerance [38]. These findings again raise the energy balance 
related impact of minor whey proteins.
Summary and Conclusions
Overall the data suggest that whey proteins (α-lactalbumin and 
β-lactoglobulin) decrease food intake, possibly by altering the plasma 
levels of hormones (CCK, GLP-1, ghrelin and insulin) important for 
energy balance regulation. In addition, whey proteins (α-lactalbumin, 
β-lactoglobulin, lactoferrin and glycomacropeptide) also alter lipid 
metabolism. This may be achieved by (1) decreasing FAS gene 
expression and hence TAG production in the liver, (2) by increasing 
lipogenesis in the muscle possibly for oxidation, and (3) by increasing 
β3-adrenergic receptor expression in the adipocytes, possibly to decrease 
FAS expression in this tissue. Whey protein intake (α-lactalbumin, 
β-lactoglobulin, lactoferrin and glycomacropeptide) improves insulin 
sensitivity and glucose tolerance, preventing high fat diet induced 
insulin resistance. With regard to energy expenditure, whey proteins 
(α-lactalbumin) increases this energy balance related parameter 
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possibly by increasing protein anabolism in the tissues. As the macro- 
and micro-nutrient (calcium) composition in the diet and obesity all 
influence the mechanisms involved in the regulation of energy balance, 
one could envisage that any changes in these mechanisms could greatly 
impact upon the ability of whey proteins to influence the balance 
between energy intake and energy expenditure. A better understanding 
of how specific whey proteins influence energy balance may help in 
the formulation of dietary interventions that could prevent or reduce 
obesity.
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